Waltham diagnostics firm Alere said Wednesday that it will delay filing its annual financial report for the second year in a row while it reviews possible accounting errors, including what the company called “inappropriate conduct” at a subsidiary in South Korea.
Alere (NYSE: ALR) said that some revenue in each of the past four years may have been recognized in the wrong periods. The changes are likely to be between $0 and $5 million for 2013 and 2014, and between $5 million and $10 million…
Waltham diagnostics firm Alere said Wednesday that it will delay filing its annual financial report for the second year in a row while it reviews possible accounting errors, including what the company called “inappropriate conduct” at a subsidiary in South Korea.
Alere (NYSE: ALR) said that some revenue in each of the past four years may have been recognized in the wrong periods. The changes are likely to be between $0 and $5 million for 2013 and 2014, and between $5 million and $10 million…